![logo](/logos/KURN.SW.webp)
Kuros Biosciences AG
SIX:KURN.SW
16.78 (CHF) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Kuros Biosciences AG |
Symbool | KURN.SW |
Munteenheid | CHF |
Prijs | 16.78 |
Beurswaarde | 604,191,402 |
Dividendpercentage | 0% |
52-weken bereik | 1.875 - 17.88 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Joost D. de Bruijn B.Sc. Ph.D., Ph.D. |
Website | https://www.kuros.ch |
An error occurred while fetching data.
Over Kuros Biosciences AG
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)